Template:Dgfn2015 So xx:00 Molekulare Methoden, neuere
(Difference between revisions)
Ossip Groth (Talk | contribs) |
Ossip Groth (Talk | contribs) |
||
Line 21: | Line 21: | ||
{{tp|p=21700819|t=2011. Circulating miR-210 predicts survival in critically ill patients with acute kidney injury |pdf=http://cjasn.asnjournals.org/content/6/7/1540.full.pdf|usr=}} | {{tp|p=21700819|t=2011. Circulating miR-210 predicts survival in critically ill patients with acute kidney injury |pdf=http://cjasn.asnjournals.org/content/6/7/1540.full.pdf|usr=}} | ||
{{tp|p=22715378|t=2012. Circulating microRNAs are not eliminated by hemodialysis |pdf=http://sm.kidney.de/epmc.php?ep=eu&pmid=22715378&pmc=3371001&ti=Circulating%20microRNAs%20are%20not%20eliminated%20by%20hemodialysis|usr=}} | {{tp|p=22715378|t=2012. Circulating microRNAs are not eliminated by hemodialysis |pdf=http://sm.kidney.de/epmc.php?ep=eu&pmid=22715378&pmc=3371001&ti=Circulating%20microRNAs%20are%20not%20eliminated%20by%20hemodialysis|usr=}} | ||
+ | |||
+ | == (Fibrose) == | ||
+ | {{tp|p=18455518|t=2008. Lysophosphatidic acid and renal fibrosis |pdf=http://sm.kidney.de/epmc.php?ep=eu&pmid=18455518&pmc=2577601&ti=Lysophosphatidic%20acid%20and%20renal%20fibrosis|usr=}} | ||
+ | ?? ncb 2009... | ||
+ | {{tp|p=23131772|t=2012. MicroRNA sequence profiles of human kidney allografts with or without tubulointerstitial fibrosis |pdf=http://sm.kidney.de/epmc.php?ep=eu&pmid=23131772&pmc=3541003&ti=MicroRNA%20sequence%20profiles%20of%20human%20kidney%20allografts%20with%20or%20without%20tubulointerstitial%20fibrosis|usr=}} | ||
+ | |||
+ | == == | ||
+ | |||
+ | |||
+ | |||
+ | |||
+ | |||
+ | |||
+ | |||
+ | |||
+ | |||
+ | |||
+ | {{tp|p=18455518|t=2008. Lysophosphatidic acid and renal fibrosis |pdf=http://sm.kidney.de/epmc.php?ep=eu&pmid=18455518&pmc=2577601&ti=Lysophosphatidic%20acid%20and%20renal%20fibrosis|usr=}} |
Revision as of 19:31, 21 September 2015
Contents |
Crispr cas system
Journal article, free access (Hinweis: First description of the cc system) |
GET 2012. A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity Extract PDF direct |
Journal article, free access |
GET 2013. Genome engineering using the CRISPR-Cas9 system Extract PDF direct |
Journal article, free access |
GET 2013. Genome engineering using the CRISPR-Cas9 system Extract PDF direct |
Journal article, free access (Hinweis: Major bioethical document) |
GET 2015. CRISPR, the disruptor Extract PDF direct |
Journal article, free access |
GET 2015. CRISPR/Cas9-mediated gene editing in human tripronuclear zygotes Extract PDF direct |
Journal Paper, restricted access |
GET 2015. BIOSAFETY Safeguarding gene drive experiments in the laboratory Extract PDF direct |
Journal Paper, restricted access |
GET 2015. Genome editing The mutagenic chain reaction: a method for converting heterozygous to homozygous mutations Extract PDF direct |
MicroRNA
Journal Paper, restricted access |
GET 2011. MicroRNAs as mediators and therapeutic targets in chronic kidney disease Extract PDF direct |
Journal Paper, restricted access |
GET 2005. Silencing of microRNAs in vivo with antagomirs Extract PDF direct |
Journal article, free access |
GET 2009. MicroRNA expression profiles predictive of human renal allograft status Extract PDF direct |
Journal article, free access |
GET 2012. MicroRNA-21 promotes fibrosis of the kidney by silencing metabolic pathways Extract PDF direct |
Journal article, free access |
GET 2014. MicroRNA-24 antagonism prevents renal ischemia reperfusion injury Extract PDF direct |
Journal article, free access |
GET 2012. Circulating and urinary microRNAs in kidney disease Extract PDF direct |
Journal article, free access |
GET 2014. Cardiac fibroblast-derived microRNA passenger strand-enriched exosomes mediate cardiomyocyte hypertrophy Extract PDF direct |
Journal article, free access |
GET 2011. Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma Extract PDF direct |
Journal article, free access |
GET 2011. Urinary miR-210 as a mediator of acute T-cell mediated rejection in renal allograft recipients Extract PDF direct |
Journal article, free access |
GET 2012. Microvesicles derived from endothelial progenitor cells protect the kidney from ischemia-reperfusion injury by microRNA-dependent reprogramming of resident renal cells Extract PDF direct |
Journal article, free access |
GET 2011. Circulating miR-210 predicts survival in critically ill patients with acute kidney injury Extract PDF direct |
Journal article, free access |
GET 2012. Circulating microRNAs are not eliminated by hemodialysis Extract PDF direct |
(Fibrose)
Journal article, free access |
GET 2008. Lysophosphatidic acid and renal fibrosis Extract PDF direct |
?? ncb 2009...
Journal article, free access |
GET 2012. MicroRNA sequence profiles of human kidney allografts with or without tubulointerstitial fibrosis Extract PDF direct |
Journal article, free access |
GET 2008. Lysophosphatidic acid and renal fibrosis Extract PDF direct |